SCHEMBL6341853

SCHEMBL6341853

CCc1nn(-c2ccccn2)c2nc3ccccc3c(Cl)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNE2 O96020 3/20 0.40
CDK4 P11802 3/20 0.40
CCND1 P24385 3/20 0.40
CCNE1 P24864 3/20 0.40
CDK2 P24941 3/20 0.40
ALDH1A1 P00352 6/20 0.39
MAPT P10636 5/20 0.39
KDM4E B2RXH2 4/20 0.39
HPGD P15428 3/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
FFAR4 Q5NUL3 1/20 0.39
NR3C1 P04150 1/20 0.37
POLB P06746 1/20 0.37
RAD52 P43351 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
CCNB2 O95067 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6344238 0.89 ALDH1A1 (0.38) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL6342619 0.85 CCNE2 (0.39) CCNE2CDK4CCND1CCNE1CDK2
Hydrochloric Acid SCHEMBL6351781 0.85 RAB9A (0.40) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL6343061 0.84 ALDH1A1 (0.46) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL6342834 0.83 ALDH1A1 (0.41) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL6344682 0.81 PIK3CD (0.39) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL6342932 0.79 NR3C1 (0.37) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL6342505 0.79 ALDH1A1 (0.54) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL6351683 0.78 ALDH1A1 (0.50) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL6343804 0.76 KDM4E (0.50) CDK2ALDH1A1MAPTKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949648-B2 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-27 US disclosed
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1270572-A1 CONDENSED PYRAZOLE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof PTGS1, PTGIS, IL5 CCNE2 1067/4885CDK4 703/4885CCND1 740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.